HK1054235A1 - 作為抗病毒藥的4-氧-1，4-二氫[1，8]-二氮雜萘-3-甲酰胺類 - Google Patents

作為抗病毒藥的4-氧-1，4-二氫[1，8]-二氮雜萘-3-甲酰胺類

Info

Publication number
HK1054235A1
HK1054235A1 HK03106506.1A HK03106506A HK1054235A1 HK 1054235 A1 HK1054235 A1 HK 1054235A1 HK 03106506 A HK03106506 A HK 03106506A HK 1054235 A1 HK1054235 A1 HK 1054235A1
Authority
HK
Hong Kong
Prior art keywords
carboxamides
naphthyridine
dihydro
oxo
antiviral agents
Prior art date
Application number
HK03106506.1A
Other languages
English (en)
Inventor
V‧A‧威蘭科特
A‧托拉雷森
Original Assignee
法瑪西雅厄普約翰美國公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 法瑪西雅厄普約翰美國公司 filed Critical 法瑪西雅厄普約翰美國公司
Publication of HK1054235A1 publication Critical patent/HK1054235A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK03106506.1A 2000-03-21 2003-09-11 作為抗病毒藥的4-氧-1，4-二氫[1，8]-二氮雜萘-3-甲酰胺類 HK1054235A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19097900P 2000-03-21 2000-03-21
PCT/US2001/005808 WO2001074816A1 (en) 2000-03-21 2001-03-15 4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxamides as antiviral agents

Publications (1)

Publication Number Publication Date
HK1054235A1 true HK1054235A1 (zh) 2003-11-21

Family

ID=22703594

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03106506.1A HK1054235A1 (zh) 2000-03-21 2003-09-11 作為抗病毒藥的4-氧-1，4-二氫[1，8]-二氮雜萘-3-甲酰胺類

Country Status (14)

Country Link
US (2) US6451811B2 (zh)
EP (1) EP1265895A1 (zh)
JP (1) JP2003529601A (zh)
KR (1) KR20020093849A (zh)
CN (1) CN1416430A (zh)
AR (1) AR030194A1 (zh)
AU (1) AU2001243240A1 (zh)
BR (1) BR0108803A (zh)
CA (1) CA2400057A1 (zh)
HK (1) HK1054235A1 (zh)
MX (1) MXPA02009249A (zh)
NZ (1) NZ521522A (zh)
WO (1) WO2001074816A1 (zh)
ZA (1) ZA200207545B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008115890A2 (en) * 2007-03-19 2008-09-25 Takeda Pharmaceutical Company Limited Mapk/erk kinase inhibitors
CA2711500A1 (en) * 2008-01-07 2009-07-16 Huanming Chen Novel hiv integrase inhibitors and methods of use
CA2873882C (en) * 2012-04-05 2020-12-15 Boehringer Ingelheim International Gmbh 1,8-naphthyridin-2(1h)-one derivatives as cytomegalovirus inhibitors
US9315499B2 (en) 2012-04-05 2016-04-19 Boehringer Ingelheim International Gmbh Cytomegalovirus inhibitor compounds
AU2017362347B2 (en) 2016-11-17 2020-09-03 The Gillette Company Llc Skin engaging member comprising ethylene vinyl acetate and a fragrance
WO2020053654A1 (en) 2018-09-12 2020-03-19 Novartis Ag Antiviral pyridopyrazinedione compounds
AU2020353055B2 (en) 2019-09-26 2024-03-07 Gilead Sciences, Inc. Antiviral pyrazolopyridinone compounds

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4568649A (en) 1983-02-22 1986-02-04 Immunex Corporation Immediate ligand detection assay
US4559157A (en) 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (fr) 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
GB8513639D0 (en) 1985-05-30 1985-07-03 Ici America Inc Cinnoline compounds
GB8702288D0 (en) 1987-02-02 1987-03-11 Erba Farmitalia Cinnoline-carboxamides
US4820508A (en) 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4992478A (en) 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
US4959363A (en) * 1989-06-23 1990-09-25 Sterling Drug Inc. Quinolonecarboxamide compounds, their preparation and use as antivirals.
AU695132B2 (en) 1995-08-02 1998-08-06 Darwin Discovery Limited Quinolones and their therapeutic use
PT841929E (pt) 1995-08-02 2003-09-30 Darwin Discovery Ltd Quinolonas e sua utilizacao terapeutica
JP2002505660A (ja) 1996-09-10 2002-02-19 ファルマシア・アンド・アップジョン・カンパニー 抗ウィルス剤としての８―ヒドロキシ―７―置換キノリン
CA2268190A1 (en) * 1997-08-06 1999-02-18 Suntory Limited 1-aryl-1,8-naphthylidin-4-one derivative as type iv phosphodiesterase inhibitor
ES2248923T3 (es) * 1997-12-22 2006-03-16 PHARMACIA & UPJOHN COMPANY LLC 4-hydroxiquinolin-3-carboxamidas y hidrazidas como agentes antivirales.
AU763636C (en) * 1998-01-29 2004-05-27 Daiichi Asubio Pharma Co., Ltd. 1-cycloalkyl-1,8-naphthyridin-4-one derivatives with phosphodiesterase IV inhibitory activity

Also Published As

Publication number Publication date
US20020019413A1 (en) 2002-02-14
AU2001243240A1 (en) 2001-10-15
KR20020093849A (ko) 2002-12-16
US20020177604A1 (en) 2002-11-28
BR0108803A (pt) 2002-11-05
WO2001074816A1 (en) 2001-10-11
EP1265895A1 (en) 2002-12-18
NZ521522A (en) 2004-08-27
AR030194A1 (es) 2003-08-13
CN1416430A (zh) 2003-05-07
US6451811B2 (en) 2002-09-17
ZA200207545B (en) 2003-12-19
MXPA02009249A (es) 2003-03-12
US6693114B2 (en) 2004-02-17
JP2003529601A (ja) 2003-10-07
CA2400057A1 (en) 2001-10-11

Similar Documents

Publication Publication Date Title
HUP0105142A3 (en) 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
IL161881A (en) N,n'-substituted-1,3-diamino-2- hydroxypropane derivatives
IL144171A0 (en) Quinolinecarboxamides as antiviral agents
IL159832A0 (en) 4-amino-6-phenyl-pyrrolo[2,3-d] pyrimidine derivatives
AU2002221344A1 (en) Antiviral agents
GB0030327D0 (en) Garment
PL351611A1 (en) 4,5,6,7-tetrahydroindazole derivatives as antitumor agents
EP1187827A4 (en) ANTIVIRAL ACTIVE SUBSTANCE
DE69904602D1 (en) Substituierte 1,8-naphthyridin-4(1h)-one als phosphodiesterase 4-inhibitoren
MXPA03000107A (es) Pirroloquinolonas como agentes antivirales.
AU6807501A (en) 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
PL358551A1 (en) 5-aminoalkyl-pyrazolo[4,3-d]pyrimidines
HK1054235A1 (zh) 作為抗病毒藥的4-氧-1，4-二氫[1，8]-二氮雜萘-3-甲酰胺類
GB0130553D0 (en) 1,4-Dihydro-1,4-diphenylpyridine derivitives
HK1054037A1 (zh) 作為抗病毒劑的4-羥基-1，8-二氮雜萘-3-羧酰胺
IL151787A0 (en) 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
AU2001285785A1 (en) 2-aminoalkyl-thieno[2,3-d]pyrimidines
IL155380A0 (en) SUBSTITUTED 3,4-DIHYDRO-PYRIDO[1,2-a] PYRIMIDINES
GB9917553D0 (en) Trousers
GB9910946D0 (en) Garment
AU2001281142A1 (en) Diazepinones as antiviral agents
AU4437401A (en) Trouser waist adjuster
GB9907383D0 (en) Garment
ZA200104710B (en) 4-Oxo-1, 4-dihydro-3-quinolinecarboxamides as antiviral agents.
PL352760A1 (en) Oxathiepino[6,5-b